Best treatments for neutropenia
15 products may treat neutropenia, spanning FDA drug classes such as leukocyte growth factor, glycopeptide antibacterial. The current highest-rated option is neulasta. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 15 drugs we list for neutropenia, 3 are available as lower-cost generics, spanning classes such as leukocyte growth factor, glycopeptide antibacterial. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for neutropenia — so confirm the right choice with your prescriber.
Understanding neutropenia
"Neutropenia" is a lab finding, not a disease: too few neutrophils, the white cells StatPearls (NCBI Bookshelf) describes as the granulated leukocytes behind "the initial immune response to inflammation and infection." StatPearls sorts the routes to a low count into two: primary, "due to decreased production or ineffective neutrophil activity," and secondary, "due to consumption or destruction of neutrophils." The numbers do the work. MedlinePlus (NLM) puts the adult threshold at fewer than 1,000 neutrophils in a microliter of blood, and calls a count below 500 severe neutropenia. StatPearls grades by circulating count: mild 1.0–1.5 x 10⁹/L, moderate 0.5–1.0, severe under 0.5, and agranulocytosis under 0.2 x 10⁹/L with absent neutrophil precursors in the marrow. What people get wrong: a low number is not automatically dangerous. StatPearls describes Duffy antigen null neutropenia (formerly termed benign ethnic neutropenia) as a low count, under 1,500 cells/μL, "without an increased infectious risk" — a variant, not a deficiency. What does change what you do next is fever during neutropenia: MedlinePlus, in its instructions for people with a low white blood cell count during cancer treatment, lists "fevers, chills, or sweats" among the symptoms that should prompt a call to your health care provider. General information, not medical advice — talk to your clinician about your own counts.
First-line treatment
There is no single "treatment for neutropenia" — care follows the cause, and the acute pathway is the one worth knowing. The 2010 IDSA guideline on antimicrobial agents in neutropenic patients with cancer defines fever as a single oral temperature ≥38.3°C (101°F), or ≥38.0°C (100.4°F) sustained over an hour, with an ANC under 500 cells/mm3 (or expected to fall below it within 48 hours). It recommends that "every patient with fever and neutropenia receive empirical antibiotic therapy urgently (ie, within 2 h) after presentation." Risk stratification decides the route: high-risk patients (anticipated prolonged, >7-day and profound neutropenia with ANC ≤100 cells/mm3, and/or significant comorbidities; MASCC score <21) are admitted for intravenous therapy; low-risk patients — brief, ≤7-day neutropenia and few or no comorbidities — are candidates for oral empirical therapy. IDSA also states hand hygiene is the most effective means of preventing transmission of infection in the hospital. For the count itself, StatPearls names granulocyte-colony stimulating factor (G-CSF) as the treatment mainstay.
Top-rated picks for neutropenia: 1. Neulasta · 2. Tyzavan · 3. Firvanq Kit
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Injectable | Leukocyte Growth Factor | No data | — | View → | |
| 2 | 72/100 | Prescription | Injectable | Glycopeptide Antibacterial | Generic | $1 | View → | |
| 3 | 70/100 | Prescription | Kit | Glycopeptide Antibacterial | Generic | $1 | View → | |
| 4 | 70/100 | Prescription | Injectable | Leukocyte Growth Factor | No data | — | View → | |
| 5 | 68/100 | Prescription | Injectable | — | No data | — | View → | |
| 6 | 68/100 | Prescription | Injectable | — | No data | — | View → | |
| 7 | 68/100 | Prescription | Injectable | — | No data | — | View → | |
| 8 | 66/100 | Prescription | Injectable | — | No data | — | View → | |
| 9 | 64/100 | Prescription | Injectable | — | No data | — | View → | |
| 10 | 60/100 | Prescription | Injectable | — | No data | — | View → |
Narrow by drug class
Explore the class hubs: glycopeptide antibacterial · leukocyte growth factor
Full ranking · 15 treatments
neulasta
PrescriptionFDA-sourced
Neulasta (Pegfilgrastim) is a leukocyte growth factor used to treat Neutropenia.
Price varies
tyzavan
Boxed warningPrescriptionFDA-sourced
Tyzavan (Vancomycin Hydrochloride) is a glycopeptide antibacterial used to treat Diarrhea, Bacterial Endocarditis, Pseudomembranous Enterocolitis, Pneumococcal Meningitis.
Pharmacy pays
From ~$0.46· 6 formsfirvanq kit
PrescriptionFDA-sourced
Firvanq Kit (Vancomycin Hydrochloride) is a glycopeptide antibacterial used to treat Diarrhea, Bacterial Endocarditis, Pseudomembranous Enterocolitis, Pneumococcal Meningitis.
Pharmacy pays
From ~$0.46· 6 formsneupogen
PrescriptionFDA-sourced
Neupogen (Filgrastim) is a leukocyte growth factor used to treat Neutropenia, Chemotherapy-Induced Febrile Neutropenia.
Price varies
stimufend
PrescriptionFDA-sourced
Stimufend (Pegfilgrastim-Fpgk) is a medication used to treat Neutropenia.
Price varies
zarxio
PrescriptionFDA-sourced
Zarxio (Filgrastim-Sndz) is a medication used to treat Neutropenia.
Price varies
Frequently asked
- What treats neutropenia?
- Our catalog lists 15 products that may treat neutropenia, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is neulasta.
- What is the best-rated treatment for neutropenia?
- By our independent recall-safety rating — not an efficacy measure — neulasta ranks highest among the products we list for neutropenia. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat neutropenia?
- Treatments for neutropenia span FDA drug classes including leukocyte growth factor, glycopeptide antibacterial. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Sources
The clinical overview above is written from these authoritative public-health and medical-society sources, independently reviewed against each.